#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14976	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2155	684.9	0	.	n	.	0	C451T	SNP	451	451	C	685	685	T	809	T,C,G	573,205,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14976	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2155	684.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	877	C	846	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14976	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2155	684.9	0	HET	.	.	.	C207T,G	.	207	207	C	441	441	C	862	C,T,G	617,198,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28138	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3447	806.7	0	.	n	.	0	T695C	SNP	695	695	T	952	952	C	818	C,T,G	791,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28138	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3447	806.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2228	2228	C	874	C,G	835,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28138	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3447	806.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2302	2302	A	869	A	836	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28138	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3447	806.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2854	2854	C	882	C,T	853,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28138	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3447	806.7	0	HET	.	.	.	A1638G,T	.	1638	1638	A	1895	1895	A	897	A,G,T	662,193,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1744	folP	855	855	100.0	folP.l15.c4.ctg.1	1457	118.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1008	1010	AGC	175;174;177	A;G;C	168;166;169	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5068	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3419	146.3	1	SNP	p	S91F	1	.	.	271	273	TTC	612	614	TTC	164;165;165	T;T;C	157;159;156	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5068	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3419	146.3	1	SNP	p	G95N	0	.	.	283	285	GGC	624	626	GGC	161;160;154	G;G;C	155;151;148	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5068	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3419	146.3	1	SNP	p	D95G	1	.	.	283	285	GGC	624	626	GGC	161;160;154	G;G;C	155;151;148	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1596	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1277	123.2	1	SNP	p	G45D	0	.	.	133	135	GGC	466	468	GGC	200;198;197	G;G;C	193;194;192	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	762	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	879	85.2	0	.	n	.	0	A197.	DEL	197	197	A	457	457	A	173	A	168	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2865	196.8	1	SNP	p	D86N	0	.	.	256	258	GAC	525	527	GAC	211;209;209	G;A;C	203;195;204	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2865	196.8	1	SNP	p	R87I	0	.	.	259	261	CGT	528	530	CGT	206;206;210	C,T;G;T	198,1;199;203	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2865	196.8	1	SNP	p	R87W	0	.	.	259	261	CGT	528	530	CGT	206;206;210	C,T;G;T	198,1;199;203	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2865	196.8	1	SNP	p	S87R	1	.	.	259	261	CGT	528	530	CGT	206;206;210	C,T;G;T	198,1;199;203	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5716	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2865	196.8	1	SNP	p	S88P	0	.	.	262	264	TCC	531	533	TCC	209;209;207	T;C;C	201;203;201	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3826	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2729	138.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1576	1578	GGC	198;194;194	G;G;C	187;184;181	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3986	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2354	166.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1228	1230	GCC	219;221;221	G;C;C,A	213;216;213,3	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3986	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2354	166.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1231	1233	ATG	216;215;214	A;T;G,C	210;210;206,3	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3986	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2354	166.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1243	1245	ACC	214;214;211	A,G;C,T;C,G,A	199,3;205,3;200,3,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3986	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2354	166.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1243	1245	ACC	214;214;211	A,G;C,T;C,G,A	199,3;205,3;200,3,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3986	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2354	166.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1744	1746	ACC	208;205;207	A,G,T;C,G;C,T	189,2,1;194,1;196,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3986	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2354	166.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1798	1800	GCG	184;182;181	G;C;G	180;177;172	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3986	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2354	166.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1798	1800	GCG	184;182;181	G;C;G	180;177;172	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3986	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2354	166.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1921	1923	GGT	125;125;122	G,A;G;T,C	119,2;120;114,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3986	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2354	166.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1930	1932	AGC	124;122;121	A,G;G;C,G	114,2;118;116,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3986	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2354	166.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1948	1950	CCG	97;99;99	C,G;C;G	77,5;81;75	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6070	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3133	191.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1679	1681	CCG	228;228;224	C;C;G	211;216;210	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2352	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1919	121.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	563	563	C	169	C,T,G	156,1,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	336	porB1a	984	285	91.0	porB1a.l6.c30.ctg.2	404	27.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	144	146	AAT	16;16;17	A;A;T	16;16;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	336	porB1a	984	285	91.0	porB1a.l6.c30.ctg.2	404	27.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	147	149	AAT	17;17;17	A;A;T	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	336	porB1a	984	285	91.0	porB1a.l6.c30.ctg.2	404	27.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	171	173	GCA	20;20;20	G;C;A	20;20;19	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	336	porB1a	984	285	91.0	porB1a.l6.c30.ctg.2	404	27.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	194	196	GTA	18;18;18	G;T;A	18;17;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	336	porB1a	984	285	91.0	porB1a.l6.c30.ctg.2	404	27.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	203	203	A	18	A	18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3086	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1689	181.2	0	.	p	.	0	G210R	NONSYN	628	630	GGA	942	944	AGA	277;273;276	A,G;G;A	265,1;260;263	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3086	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1689	181.2	0	.	p	.	0	S217G	NONSYN	649	651	AGT	963	965	GGT	265;268;269	G,A;G,A;T	250,2;255,1;251	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3086	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1689	181.2	1	SNP	p	G120K	1	.	.	358	360	AAG	672	674	AAG	245;246;250	A;A;G	229;230;235	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3086	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1689	181.2	1	SNP	p	A121N	1	.	.	361	363	AAC	675	677	AAC	247;246;247	A,G;A;C,A	229,3;233;227,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3086	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1689	181.2	1	SNP	p	N121D	0	.	.	361	363	AAC	675	677	AAC	247;246;247	A,G;A;C,A	229,3;233;227,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10950	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4825	224.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1282	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	939	135.0	1	SNP	p	V57M	1	.	.	169	171	ATG	483	485	ATG	251;250;250	A;T;G,A	243;240;239,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
